Daniel E. Geffken Eloxx Pharmaceuticals, Inc. (ELOX) insider trading activity

ELOX Quotes by TradingView

Daniel E. Geffken is INTERIM CFO of Eloxx Pharmaceuticals, Inc.. Currently has a direct ownership of 50,000 shares of ELOX, which is worth approximately $0. The most recent transaction as insider was on Nov 29, 2021, when has been sold 50,000 shares (Common Stock) at a price of $0.72 per share, resulting in proceeds of $36,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 50K
0% 3M change
0% 12M change
Total Value Held $0

Daniel E. Geffken Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 29 2021
BUY
Open market or private purchase
$36,000 $0.72 p/Share
50,000 Added 50.0%
50,000 Common Stock

Also insider at

EFTR
eFFECTOR Therapeutics, Inc. Healthcare
Chief Financial Officer
WINT
WINDTREE THERAPEUTICS INC Healthcare
Director
PBAXU
PHOENIX BIOTECH ACQUISITION CORP. Financial Services
Chief Financial Officer
GRAY
GRAYBUG VISION, INC. Healthcare
Interim CFO
PMN
ProMIS Neurosciences Inc.
Chief Financial Officer
DEG

Daniel E. Geffken

INTERIM CFO
Philadelphia, PA

Track Institutional and Insider Activities on ELOX

Follow Eloxx Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ELOX shares.

Notify only if

Insider Trading

Get notified when an Eloxx Pharmaceuticals, Inc. insider buys or sells ELOX shares.

Notify only if

News

Receive news related to Eloxx Pharmaceuticals, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on ELOX